Sudomotor dysfunction in patients recovered from COVID-19 - 14/03/21
, Abdul Moutairou b, Jean-Henri Calvet b
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.
Conéctese para beneficiarse!
Abstract |
Dysautonomia has been reported in COVID-19. Sweat function testing has been proposed to assess autonomic neuropathy. Fifty Indian patients consulting for neurological symptoms participated in this observational study. The NHS questionnaire for neurological symptoms was completed and electrochemical skin conductance was measured using Sudoscan. The 26% of patients with sweat dysfunction i) were older (p = 0.001), ii) were more frequently treated at home (p = 0.008), iii) were more likely to have received antiviral treatment (p = 0.0006), and iv) more frequently reported at least one motor, sensory or autonomic symptom (p = 0.04). This preliminary study suggests that patients with COVID-19 should be screened for dysautonomia.
El texto completo de este artículo está disponible en PDF.Keywords : COVID-19, Dysautonomia, Electrochemical skin conductance, Small fiber neuropathy
Esquema
Vol 51 - N° 2
P. 193-196 - mars 2021 Regresar al número
Artículo precedente
- Electrophysiological features of acute inflammatory demyelinating polyneuropathy associated with SARS-CoV-2 infection
- Antonino Uncini, Camillo Foresti, Barbara Frigeni, Benedetta Storti, Maria Cristina Servalli, Stefano Gazzina, Giuseppe Cosentino, Francesca Bianchi, Ubaldo Del Carro, Enrico Alfonsi, Stefano Cotti Piccinelli, Giovanni De Maria, Alessandro Padovani, Massimiliano Filosto, Luigi Ippoliti
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.